Vol 81, No 8 (2010)
ARTICLES

open access

Page views 2736
Article views/downloads 2418
Get Citation

Connect on Social Media

Connect on Social Media

Statins in the treatment of polycystic ovary syndrome

Beata Banaszewska, Robert Spaczyński, Leszek Pawelczyk
Ginekol Pol 2010;81(8).

Abstract

Summary Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting 6-9% of women in reproductive age. It is characterized by hyperandrogenism, oligo- or anovulation and infertility. PCOS is associated with important cardiovascular risk factors including: obesity, dyslipidemia , systemic inflammation and endothelial dysfunction. Statins are well-tested medications reducing a broad range of cardiovascular risk factors. The primary mode of action of statins is inhibition of HMG-Co A reductase, a rate-limiting step of cholesterol synthesis. In recent randomized studies in PCOS women, statins have decreased testosterone level, improved menstrual cycle regularity and lipid profile.

Article available in PDF format

View PDF Download PDF file